Chapter 1. Research Objective
1.1 Objective, Definition & Scope
1.2 Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Forecast - Estimation & Approach
1.2.4 Assumptions & Assessments
1.3 Insights and Growth - Relevancy Mapping
1.3.1 FABRIC Platform
1.4 Data mining & efficiency
Chapter 2. Executive Summary
2.1 Haemodialysis and Peritoneal Dialysis Market Overview
2.2 Interconnectivity & Related markets
2.3 Ecosystem Map
2.4 Haemodialysis and Peritoneal Dialysis Market Business Segmentation
2.5 Haemodialysis and Peritoneal Dialysis Market Geographic Segmentation
2.6 Competition Outlook
2.7 Key Statistics
Chapter 3. Strategic Analysis
3.1 Haemodialysis and Peritoneal Dialysis Market Revenue Opportunities
3.2 Cost Optimization
3.3 Covid19 aftermath - Analyst view
3.4 Haemodialysis and Peritoneal Dialysis Market Digital Transformation
Chapter 4. Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PEST Analysis
4.2.1 Political
4.2.2 Economic
4.2.3 Social
4.2.4 Technological
4.3 Market Impacting Trends
4.3.1 Positive Impact Trends
4.3.2 Adverse Impact Trends
4.4 Porter's 5-force Analysis
4.5 Market News - By Segments
4.5.1 Organic News
4.5.2 Inorganic News
Chapter 5. Market Segmentation
The Haemodialysis and Peritoneal Dialysis Market has been analysed to include the below segmentation:
By Type
• Hemodialysis
• Peritoneal Dialysis
By Dialysis Site
• Hospitals
• Clinics and Dialysis Centers
• Home Dialysis
By Modality
• Conventional
• Daily (Day Time, Night Time)
By Product
• Devices
• Consumables
Chapter 5A. Regional Segmentation
The Haemodialysis and Peritoneal Dialysis Market has been analysed by studying the following regions:
North America
• By Type
• By Dialysis Site
• By Modality
• By Product
Europe
• By Type
• By Dialysis Site
• By Modality
• By Product
APAC
• By Type
• By Dialysis Site
• By Modality
• By Product
LatAm
• By Type
• By Dialysis Site
• By Modality
• By Product
MEA
• By Type
• By Dialysis Site
• By Modality
• By Product
**The Regions are further studied to analyse the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include:
• North America - United States, Canada, Mexico;
• Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe;
• Asia Pacific - China, India, Japan, South Korea, Rest of APAC;
• Middle East & Africa - South Africa, GCC Countries, Rest of MEA;
• Latin America - Brazil, Argentina, Rest of LatAm;
Chapter 6. Market Use case studies
Chapter 7. KOL Recommendations
Chapter 8. Investment Landscape
8.1 Haemodialysis and Peritoneal Dialysis Market Investment Analysis
8.2 Market M&A
8.3 Market Fund Raise & Other activity
Chapter 9. Haemodialysis and Peritoneal Dialysis Market - Competitive Intelligence
9.1 Company Positioning Analysis
9.1.1 Positioning - By Revenue
9.1.2 Positioning - By Business Score
9.1.3 Legacy Positioning
9.2 Competitive Strategy Analysis
9.2.1 Organic Strategies
9.2.2 Inorganic Strategies
Chapter 10. Key Company Profiles
*The Haemodialysis and Peritoneal Dialysis Market Report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.
Companies are typically profiled to include:
10.x.1 Company Fundamentals
10.x.2 Performance Overview
10.x.3 Product Overview
10.x.4 Recent Developments
Key Companies profiled in this report include:
• FRESENIUS SE AND CO. KGAA
• ASAHI KASEI CORPORATION
• B. BRAUN MELSUNGEN AG
• BAXTER INTERNATIONAL INC.
• BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
• COOK GROUP
• ANGIODYNAMICS INC.
• MEDTRONIC PLC.
• NIKKISO CO. LTD.
• NIPRO CORPORATION
Chapter 11. Appendix
11.1 About AllTheResearch (ATR)
11.2 ATR Services
11.3 Author details
11.4 Terms & Conditions
11.5 Contact us